uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 13, 2012

Alistrol Health Inc. Warned Over Health Claims on Products

On June 26, 2012, the FDA issued a warning letter to Alistrol Health Inc. for making product statements on the company's websites that constitute drug claims. As a result, the FDA has designated the following Alistrol products, which have been marketed like supplements, as unapproved drugs: Alistrol, CLE Vitamin D3, Naavudi, and Depression Fighters.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at